Fatty Liver Reversal
Is Possible. Here's How.
India's first metabolonomics-based telehealth program for NAFLD — treating the root cause, not just the ultrasound report.
Fatty liver is the fastest-growing liver disease in India. Over 38% of urban Indians now have some degree of hepatic steatosis — most without any symptoms. Left unaddressed, Grade 1 fatty liver can silently progress to Grade 2, Grade 3 (NASH), and eventually cirrhosis. The window to reverse it completely is now, while the liver can still regenerate.
Understanding the condition
What Is Fatty Liver Disease (NAFLD)?
Non-Alcoholic Fatty Liver Disease (NAFLD) occurs when excess fat — more than 5% of liver weight — accumulates in liver cells. In India, the primary drivers are not alcohol but metabolic dysfunction: insulin resistance, central obesity, and poor dietary patterns.
🔍 Common Root Causes
- ➔ Insulin resistance & hyperinsulinaemia
- ➔ Central obesity / visceral fat excess
- ➔ High refined carbohydrate & sugar intake
- ➔ Sedentary lifestyle & poor sleep
- ➔ Hormonal imbalance (PCOS, hypothyroidism)
- ➔ Cortisol dysregulation / chronic stress
- ➔ Gut microbiome disruption
🩺 How It Presents
- ➔ Often completely silent — found on routine ultrasound
- ➔ Persistent fatigue and low energy
- ➔ Mild right upper abdominal discomfort
- ➔ Unexplained weight gain, especially belly fat
- ➔ Elevated SGPT / SGOT on blood tests
- ➔ High triglycerides or fasting insulin
- ➔ Bloating, sluggish digestion
| Grade | What the Ultrasound Shows | Reversibility | Urgency |
|---|---|---|---|
| Grade 1 (Mild) | Slight increase in liver echogenicity; portal vein visible | Highly Reversible | Start now — full reversal achievable |
| Grade 2 (Moderate) | Moderate echogenicity; portal vein slightly obscured | Reversible | Structured intervention required |
| Grade 3 (Severe / NASH) | Marked echogenicity; diaphragm poorly seen | Requires Medical Oversight | Advanced clinical management needed |
Our Scientific Differentiator
Why Most Fatty Liver Programs Fail — And What We Do Differently
Generic diet plans and standard "eat less, move more" advice fail because they ignore the why behind your fatty liver. Teledoc's TMWLP program is built on metabolonomics — a precision-medicine framework that identifies your specific metabolic phenotype before designing your treatment plan.
Insulin Resistance Type
Elevated fasting insulin, high HOMA-IR. The most common fatty liver phenotype in India. Requires carb periodisation and targeted GLP-1 therapy.
Cortisol Excess Type
Stress-driven visceral fat deposition and HPA axis dysregulation. Requires cortisol rhythm correction alongside dietary intervention.
Thyroid-Driven Type
Subclinical or overt hypothyroidism causing reduced fatty acid oxidation. Optimising thyroid function unlocks liver fat mobilisation.
Mixed / Complex Type
Multiple overlapping drivers — common in PCOS, prediabetes, and metabolic syndrome. Requires a multi-axis, layered treatment approach.
The Program
How the Fatty Liver Reversal Program Works
Our five-pillar protocol addresses every metabolic driver of hepatic steatosis — from your plate to your pharmacy, from your sleep schedule to your stress response.
Metabolic Phenotyping First
Before any prescription or diet chart is issued, you undergo a structured metabolic assessment. Blood work including fasting insulin, HOMA-IR, HbA1c, thyroid panel, and liver enzymes is reviewed to classify your phenotype. This single step is what separates us from every generic weight loss program. Your plan is built on your biology, not averages.
Indian Vegetarian-Optimised Diet Plan
Our dietitian designs a personalised, anti-inflammatory, high-protein meal plan built around Indian vegetarian foods. We deliberately chose a diet closest to what an Indian household operates, not a Mediterranean diet brochure. Meals are planned around your regional cuisine, cooking styles, and festival calendar — with specific focus on reducing hepatic fat load through smart carbohydrate management, liver-protective foods like methi, karela, and haldi, and adequate plant-based protein from soya, paneer, chana, and legumes.
GLP-1 Therapy (Where Indicated)
GLP-1 receptor agonists — semaglutide and tirzepatide — have demonstrated direct hepatoprotective effects beyond weight loss, reducing liver fat, SGPT levels, and hepatic inflammation in clinical trials. Where your phenotype indicates GLP-1 suitability, Dr. Nitin Jain initiates a medically supervised protocol at the appropriate starting dose, titrated based on your tolerance and response. This is not a shortcut. It is precision pharmacotherapy used alongside lifestyle change, not instead of it.
Movement & Lifestyle Correction
Even 150 minutes of weekly moderate activity — a brisk evening walk — can meaningfully reduce liver fat. Our fitness expert designs a progressive movement plan calibrated to your current fitness level, joint health, and schedule. Beyond exercise, sleep architecture and cortisol patterns are addressed directly — fat excess and poor sleep quality are well-established contributors to hepatic steatosis progression.
Ongoing Monitoring & Lab Tracking
Fatty liver reversal is measurable. We track SGPT, SGOT, fasting insulin, triglycerides, and body weight at regular intervals. Repeat ultrasound is recommended at 3–6 months. Your progress is reviewed at every follow-up — plans are adjusted dynamically, not discarded, after the first few months. We partner with Dr. Lal PathLabs, SRL, Metropolis and Thyrocare for affordable, doorstep lab collection across India.
What to Expect
Outcomes Patients Typically Experience
Results depend on grade severity, adherence, and phenotype. With a structured, supervised program, most patients with Grade 1–2 fatty liver see meaningful improvement within 3–6 months.
Reduced Liver Fat
Measurable improvement on repeat ultrasound within 3–6 months of consistent program adherence.
Normalised SGPT / SGOT
Liver enzyme levels typically begin improving within 4–8 weeks of metabolic correction.
Sustained Weight Loss
Particularly visceral and abdominal fat — the most metabolically harmful depot.
Improved Insulin Sensitivity
Lower fasting insulin and HOMA-IR, reducing progression risk to diabetes and NASH.
Better Energy & Digestion
Reduced fatigue, bloating, and mid-day energy crashes as metabolic health improves.
Reduced Long-Term Risk
Lower risk of NASH, liver fibrosis, Type 2 diabetes, and cardiovascular complications.
Is This Right for You?
Who Should Consider This Program
This program is designed for adults who have been diagnosed with NAFLD or suspect they may have it — and who want a medically supervised, root-cause approach rather than generic diet advice.
Get Started Today
Your Liver Can Recover.
Let's Make It Happen.
Book a consultation with Dr. Nitin Jain. Bring your latest ultrasound report and blood work — we'll map your metabolic phenotype and design your personalised reversal plan in the first session.